Publications

Journal Articles

  1. & Corrigendum to Metabolomic-based biomarker discovery for non-invasive lung cancer screening: A case study [Biochimica et Biophysica Acta (BBA) – General subjects, vol. 1860 (2016), pp. 2682–2687]. Biochimica et Biophysica Acta (BBA) - General Subjects
  2. & Metagenomic Sequencing of the Chronic Obstructive Pulmonary Disease Upper Bronchial Tract Microbiome Reveals Functional Changes Associated with Disease Severity. PLOS ONE 11(2), e0149095
  3. & A New Class of Safe Oligosaccharide Polymer Therapy To Modify the Mucus Barrier of Chronic Respiratory Disease. Molecular Pharmaceutics 13(3), 863-872.
  4. & The metabolomic detection of lung cancer biomarkers in sputum. Lung Cancer 94, 88-95.
  5. & Vibrational spectra, principal components analysis and the horseshoe effect. Vibrational Spectroscopy 81, 62-67.
  6. & Reply to the letter to the editor 'Measured and estimated glomerular filtration rate for carboplatin dose calculation' by Cathomas et al.. Annals of Oncology 26(1), 249-250.
  7. Histological features and tissue microarray taxonomy of Nigerian breast cancer reveal predominance of the high grade triple negative phenotype. Pathobiology
  8. & MutAIT: an online genetic toxicology data portal and analysis tools. Mutagenesis, gev050
  9. & Increased expression of ARF GTPases in prostate cancer tissue. SpringerPlus 4(1)
  10. & Base damage, local sequence context andTP53mutation hotspots: a molecular dynamics study of benzo[a]pyrene induced DNA distortion and mutability. Nucleic Acids Research 43(19), 9133-9146.
  11. A prospective randomised study of transvaginal ultrasound effects of tamoxifen and exemestane in postmenopausal women with early breast cancer. Tumori. Nov-Dec;():620-4 100(6), 620-624.
  12. & A role for STEAP2 in prostate cancer progression. Clinical & Experimental Metastasis 31(8), 909-920.
  13. & Fourier transform infrared for noninvasive optical diagnosis of oral, oropharyngeal, and laryngeal cancer. Translational Research 163(1), 19-26.
  14. & Prediction of glycoprotein secondary structure using ATR-FTIR. Vibrational Spectroscopy 69, 21-29.
  15. Commentary on “Profiling serologic biomarkers in cirrhotic patients via high-throughput Fourier transform infrared spectroscopy: toward a new diagnostic tool of hepatocellular carcinoma”. Translational Research 162(5), 275-278.
  16. et. al. Putative prognostic epithelial-to-mesenchymal transition biomarkers for aggressive prostate cancer. Experimental and Molecular Pathology 95(2), 220-226.
  17. & Detection of Lewis antigen structural change by FTIR spectroscopy. Carbohydrate Polymers 92(2), 1294-1301.
  18. & A comparison of measured and estimated glomerular filtration rate for carboplatin dose calculation in stage I testicular seminoma. Medical Oncology 30(3)
  19. et. al. Influence of DNA Repair on Nonlinear Dose-Responses for Mutation. Toxicological Sciences 132(1), 87-95.
  20. & A Comprehensive Survey of Ras Mutations in Cancer. Cancer Research 72(10), 2457–67
  21. Investigating mechanisms for non-linear genotoxic responses, and analysing their effects in binary combination. Genes and Environment
  22. et. al. Curcumin abrogates bile-induced NF-κB activity and DNA damage in vitro and suppresses NF-κB activity whilst promoting apoptosis in vivo, suggesting chemopreventative potential in Barrett’s oesophagus. Clinical and Translational Oncology 14(4), 302-311.
  23. & Decision-making tools to assist prognosis and treatment choices in early breast cancer: a review. Expert Review of Anticancer Therapy 12(8), 1033-1043.
  24. et. al. Loss of WT1 Expression in the Endometrium of Infertile PCOS Patients: A Hyperandrogenic Effect?. The Journal of Clinical Endocrinology & Metabolism 97(3), 957-966.
  25. Using XML to encode TMA DES metadata. Journal of Pathology Informatics 2(40)
  26. The tissue microarray data exchange specification: Extending TMA DES to provide flexible scoring and incorporate virtual slides. Journal of Pathology Informatics
  27. Extending the tissue microarray data exchange specification for inclusion of data analysis results. Journal of Pathology Informatics 2(17)
  28. & Staphylococci and Staphylococcal Superantigens in Asthma and Rhinitis: A Systematic Review and Meta-analysis. Allergy 66, 549¨C555
  29. & Evaluation of FTIR Spectroscopy as a diagnostic tool for lung cancer using sputum. BMC Cancer 10, 640
  30. & Atomic force microscopy comes of age. Biology of the cell 102, 133-143.
  31. et. al. L-Selectin ligands in human endometrium: comparison of fertile and infertile subjects. Human Reproduction 24(11), 2767-2777.
  32. & A study of mitochondrial DNA D-loop mutations and p53 status in nonmelanoma skin cancer. British Journal of Dermatology 161, 1067-1071.
  33. & Progesterone induces nano-scale molecular modifications on endometrial epithelial cell surfaces. Biology of the cell 101, 481¨C493
  34. & Array CGH demonstrates characteristic aberration signatures in human papillary thyroid carcinomas governed by RET/PTCArray CGH on PTC. Oncogene 27, 4592-4602.
  35. & Comparison of induced and cancer-associated mutational spectra using multivariate data analysis. Carcinogenesis 29, 772-778.
  36. & Mutagenicity of tamoxifen DNA adducts in human endometrial cells and in silico prediction of p53 mutation hotspots. Nucleic Acids Research 36(18), 5933-5945.
  37. & Thein vitroanti-tumour activity of zoledronic acid and docetaxel at clinically achievable concentrations in prostate cancer. Acta Oncologica 46(5), 669-677.
  38. & Profiling the Breast Cancer Proteome — The New Tool of the Future?. Clinical Oncology 18(8), 581-586.
  39. & iMARS—Mutation analysis reporting software: An analysis of spontaneous cII mutation spectra. Mutation Research/Genetic Toxicology and Environmental Mutagenesis 603(1), 15-26.
  40. et. al. Mitochondrial DNA mutations in oral squamous cell carcinoma. Carcinogenesis 27(5), 945-950.
  41. Novel human pathological mutations. Human Genetics 118(6), 774-785.
  42. Mitochondrial DNA mutations in oral squamous cell carcinoma. Carcinogenesis 27(5), 945-950.
  43. & A combination drug therapy improves cognition and reverses gene expression changes in a mouse model of Huntington's disease. European Journal of Neuroscience 21(4), 855-870.
  44. In silico p53 mutation hotspots in lung cancer. Carcinogenesis 25(7), 1099-1107.
  45. & An exploratory analysis of multiple mutation spectra. Mutation Research/Genetic Toxicology and Environmental Mutagenesis 518(2), 163-180.
  46. & Mitochondrial DNA mutations in the parotid gland of cigarette smokers and non-smokers. Mutation Research/Genetic Toxicology and Environmental Mutagenesis 518(1), 47-54.
  47. Spontaneous mutation spectra in supF: comparative analysis of mammalian cell line base substitution spectra. Mutagenesis 16(6), 503-515.
  48. The Mammalian Gene Mutation Database. Mutagenesis 15(5), 411-414.
  49. & Authors' reply. Mitochondrial DNA damage and oncocytic neoplasia. The Journal of Pathology 192(4), 563-563.
  50. & Detection of damage to the mitochondrial genome in the oncocytic cells of Warthin's tumour. The Journal of Pathology 191(3), 274-281.

Books

  1. R for Medicine and Biology. Boston: Jones & Bartlett Publishers,.

Other Research Outputs

  1. Ref:P100088GB - COPD Detection.
  2. Ref:P100032WO - Lung cancer diagnosis.
  3. Ref:P100032GBN - Lung cancer diagnosis.